Navigation Links
Mylan Reports Third Quarter 2013 Adjusted Diluted EPS of $0.82
Date:10/31/2013

period. After adjusting for certain items as further detailed below, adjusted EBITDA was $1.44 billion for the nine months ended September 30, 2013 and $1.43 billion for the comparable prior year period.

Cash FlowAdjusted cash provided by operating activities was $727 million for the nine months ended September 30, 2013, compared to $823 million for the comparable prior year period. On a GAAP basis, cash provided by operating activities was $689 million for the nine months ended September 30, 2013, compared to $658 million for the comparable prior year period. Capital expenditures were approximately $239 million in the current year as compared to approximately $160 million in the same prior year period. The increase in capital expenditures as compared to 2012 is the result of expenditures to expand our global operating platform, including capital investments in our strategic growth drivers.

On October 29, 2013, the Board of Directors of the Company approved the repurchase of up to $500 million of the Company's common stock. This share repurchase plan will be financed with our available cash on hand, revolver borrowings or future debt issuances. The repurchase program does not obligate the Company to acquire any particular amount of common stock.

Non-GAAP Financial MeasuresMylan is disclosing non-GAAP financial measures when providing financial results. Primarily due to acquisitions, Mylan believes that an evaluation of its ongoing operations (and comparisons of its current operations with historical and future operations) would be difficult if the disclosure of its financial results were limited to financial measures prepared only in accordance with accounting principles generally accepted in the U.S. (GAAP). In addition to disclosing its financial results determined in accordance with GAAP, Mylan is disclosing certain non-GAAP results that exclude items such as amortization expense and other costs directly associated with the acquisitions as
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
2. Mylan to Speak at the Morgan Stanley Global Healthcare Unplugged Conference
3. Mylan to Speak at the Bank of America Merrill Lynch Global Healthcare Conference
4. Mylan Announces Completion of Transdermal Patch Facility Expansion Project in St. Albans, Vt.
5. Mylan Acquisition of Agila Receives Approval from Indias Foreign Investment Promotion Board and Cabinet Committee on Economic Affairs
6. Mylan Confirms Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
7. Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68
8. Third Circuit Rules in Mylans Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylans Breach of Contract Claim Against GSK to Trial
9. Mylan to Host Investor Day on Aug. 1, 2013 in New York City
10. Roger Graham Named President of Mylan Specialty
11. Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... September 30, 2014 , ... feature in-store events will change the way retail pharmaceutical ... the way we use and view pharmacies, Health First ... By catering to the very trendy public demands of ... of in-store events with various activities for both children ...
(Date:9/30/2014)... LONDON , Sept. 30, 2014 ... America Nutraceuticals Industry Outlook to 2017 - Increasing ... a comprehensive analysis of the industry past, present ... and Canada market with ... beverages and dietary supplements. Additionally the sub-segments of ...
(Date:9/30/2014)... , September 30, 2014 Investor-Edge ... (NASDAQ: IMMU ), Aeterna Zentaris Inc. (NASDAQ: ... OPK ), Navidea Biopharmaceuticals Inc. (NYSE MKT: NAVB), ... these five companies can be accessed at: http://investor-edge.com/register ... NASDAQ Composite ended at 4,505.85, down 0.14%, the Dow ...
Breaking Medicine Technology:Health First Pharmacy Redefines 'Pharmacy Retail Experience' 2Health First Pharmacy Redefines 'Pharmacy Retail Experience' 3North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 2North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 2Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 4Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 5
... every clinical laboratory possesses one essential devicea centrifuge. ... refrigerated or non-cooled, but this apparatus, because of ... creating spin-induced high g-forces, has long been a ... For all this utility, these machines are true ...
... (EBV), which causes infectious mononucleosis (IM), is one of ... most people become infected with EBV sometime during their ... percent of adults between 35 and 40 years of ... the U.S., infection with EBV most often occurs during ...
Cached Medicine Technology:Bench-Top Centrifuges--Basic Tools for the Small Lab 2Bench-Top Centrifuges--Basic Tools for the Small Lab 3Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 2Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 3
(Date:9/30/2014)... 30, 2014 Sheridan Healthcare, ... the nation, today announced that Adam Blomberg, MD, ... division, will present at the Society for Healthcare ... Connections 2014 . The conference will be held ... Connections is a four-day conference that draws in ...
(Date:9/30/2014)... Visit Pam and Steve’s quiet home in the ... a loving couple facing the most monumental challenge of ... Steve was diagnosed with ALS – more commonly known ... the couple’s second wedding anniversary. Pam is now ... “Care, Support & ALS,” that’s part of the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Houstonians seeking ... a place to visit on the Internet. Paul ... Houston’s most respected cosmetic surgeons, has launched a new ... the benefits of Botox Cosmetic services. The ... , According to the new website, Botox Cosmetic ...
(Date:9/30/2014)... Edward D. Buckingham, M.D., owner of the Buckingham ... be a director of a fellowship for the American ... program. The announcement came last week from the AAFPRS ... and Research Foundation for the AAFPRS fellowship program is ... postgraduate program in the world for the training of ...
(Date:9/30/2014)... TrailMyx.com —the country’s leading purveyor of ... Month: raw pumpkin seeds. , Pumpkin seeds—also known as ... protein, and valued by experts as an excellent source ... E. They are prized for their contributions to bone ... , Of course, pumpkin seeds are closely associated with ...
Breaking Medicine News(10 mins):Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 2Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 3Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:TrailMyx.com Features October Flavor of the Month 2
... which is set to appear online later in ... the possible implications for traumatic brain injury (TBI) ... anti-inflammatory drugs (NSAIDS) as ibuprofen for chronic pain. ... humans have shown that long-term use of ibuprofen ...
... Children's Research Hospital it was found that a gene responsible ... also initiate leukemias. // ,This gene results in leukemia ... The discovery of the normal function of this gene suggests ... form might be used in leukemia patients with few serious ...
... certain genetic variation, along with inflammatory factors and smoking, ... macular degeneration, according to a study.// ,Age-related macular ... visual loss in the elderly of the Western world, ... play a role in AMD, and inflammation also may ...
... British schools are concerned that children in primary schools ... schools to tackle inappropriate// sexual behaviour. ,Children ... other in a rather "sexualised" manner with games such ... enough not to set alarm bells ringing. ...
... relied on humid air to relieve the barking cough and ... sends worried families to the emergency room. Now a new ... little medical benefit. ,“Typically you get people to ... you get them to boil a kettle in the room, ...
... that the elderly should not be barred from stroke rehabilitation ... the older a stroke victim, the less are the chances ... people over 80 years of age can recover as much ... the researchers studied 878 stroke survivors who received rehabilitation in ...
Cached Medicine News:Health News:Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 3Health News:Genetic Variation Linked to Age-Related Macular Degeneration 2Health News:Humid Air is Little Help for Croup's Barking Cough 2Health News:Humid Air is Little Help for Croup's Barking Cough 3